Neuralink, the brain-chip company founded by Elon Musk, has been granted the "breakthrough device" designation by the US Food and Drug Administration for its experimental implant known as Blindsight.
This innovative device aims to restore vision for individuals suffering from complete or partial blindness, including those with non-functional optic nerves.
Neuralink announced on its X page, "We have received Breakthrough Device Designation from the FDA for Blindsight. Join us in our quest to bring back sight to those who have lost it. Apply to our Patient Registry and openings on our career page."
The FDA's breakthrough designation is awarded to medical devices that address life-threatening conditions, facilitating their development and review process, as reported by Reuters.
Musk also shared this update on his X social media platform, emphasizing Blindsight's capability to restore vision even in the most severe cases of blindness.
He stated, "The Blindsight device from Neuralink will enable even those who have lost both eyes and their optic nerve to see. If the visual cortex remains intact, it will allow those who have been blind from birth to experience sight for the first time.
Initially, the vision will be low resolution, akin to Atari graphics, but it has the potential to surpass natural vision and allow perception in infrared, ultraviolet, or even radar wavelengths, similar to Geordi La Forge."
Founded in 2016, Neuralink focuses on creating advanced brain-computer interfaces aimed at revolutionizing the treatment of neurological disorders.
The company's technology features a brain implant that interprets neural signals and wirelessly communicates with external devices, such as computers and smartphones.
Additionally, Business World reports that Neuralink is working on an implant that would enable paralyzed individuals to control digital devices using their thoughts.
Neuralink is reportedly engaged in a clinical trial involving three participants to assess the efficacy of its device in assisting individuals with spinal cord injuries.
In August 2024, it was widely reported that the brain-computer interface developed by Neuralink was successfully implanted in a second patient, who is now able to control video games and create 3D designs solely through thought.